Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults

Shiwei Zhou; Samuel L Aitken

doi:10.1001/jama.2023.9844

Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults

JAMA. 2023 Jul 11;330(2):182-183. doi: 10.1001/jama.2023.9844.

Authors

Shiwei Zhou¹, Samuel L Aitken²

Affiliations

¹ Department of Internal Medicine, Division of Infectious Diseases, Michigan Medicine, Ann Arbor.
² Department of Pharmacy, Michigan Medicine, Ann Arbor.

PMID: 37358837
DOI: 10.1001/jama.2023.9844

No abstract available

Plain language summary

This JAMA Insights Clinical Update discusses current recommendations regarding prevention of Pneumocystis pneumonia in patients who are immunocompromised.

MeSH terms

Adult
Chemoprevention
Humans
Immunocompromised Host
Pneumocystis carinii*
Pneumonia, Pneumocystis* / drug therapy
Pneumonia, Pneumocystis* / microbiology
Pneumonia, Pneumocystis* / prevention & control
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

Trimethoprim, Sulfamethoxazole Drug Combination